ENDRA Life Sciences (NDRA) Accumulated Expenses (2016 - 2025)
ENDRA Life Sciences (NDRA) posted quarterly Accumulated Expenses of $448419.0 for Q2 2025, up 37.55% year-over-year from $326010.0 in Q2 2024, and up 286.03% quarter-over-quarter from $116163.0 in Q1 2025.
ENDRA Life Sciences (NDRA) Accumulated Expenses (2016 - 2025) Analysis & Trends
ENDRA Life Sciences (NDRA) has reported Accumulated Expenses for 10 consecutive years, with $448419.0 the latest figure, recorded in Q2 2025.
- In Q2 2025, Accumulated Expenses rose 37.55% year-over-year to $448419.0; the TTM figure through Jun 2025 stood at $448419.0 (up 37.55% YoY), while the FY2024 annual figure was $63140.0, down 57.99% from the prior year.
- Accumulated Expenses climbed to $448419.0 in Q2 2025 per NDRA's latest filing, from $116163.0 in the prior quarter.
- Across five years, Accumulated Expenses topped out at $1.5 million in Q1 2021 and bottomed at $60638.0 in Q4 2022.
- Historically, Accumulated Expenses has averaged $343978.5 across 5 years, with a median of $202226.0 in 2023.
- Annual changes were most pronounced in 2022 — Accumulated Expenses tumbled 90.01% — and 2023, when it jumped 147.85%.
- ENDRA Life Sciences' Accumulated Expenses stood at $101459.0 in 2021, then sank by 40.23% to $60638.0 in 2022, then surged by 147.85% to $150293.0 in 2023, then tumbled by 57.99% to $63140.0 in 2024, then jumped by 610.2% to $448419.0 in 2025.
- Business Quant data shows NDRA's Accumulated Expenses at $448419.0 in Q2 2025, $116163.0 in Q1 2025, and $63140.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn |
| 10 | ENDRA Life Sciences | 5.44 Mn | 5.08 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 448,419.00 |
| Mar 31, 2025 | 116,163.00 |
| Dec 31, 2024 | 63,140.00 |
| Sep 30, 2024 | 133,355.00 |
| Jun 30, 2024 | 326,010.00 |
| Mar 31, 2024 | 266,058.00 |
| Dec 31, 2023 | 150,293.00 |
| Sep 30, 2023 | 273,007.00 |
| Jun 30, 2023 | 202,226.00 |
| Mar 31, 2023 | 216,426.00 |
| Dec 31, 2022 | 60,638.00 |
| Sep 30, 2022 | 164,357.00 |
| Jun 30, 2022 | 210,766.00 |
| Mar 31, 2022 | 151,322.00 |
| Dec 31, 2021 | 101,459.00 |
| Sep 30, 2021 | 1.45 Mn |
| Mar 31, 2021 | 1.51 Mn |
| Dec 31, 2020 | 48,260.00 |
| Dec 31, 2019 | 94,862.00 |
| Dec 31, 2018 | 29,302.00 |